Dynamic Context Retrieval for AI Protein and Drug Reasoning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The drug development pipeline is lengthy and costly due to a lack of machine learning algorithms that effectively leverage massive protein-related information, and existing methods do not utilize dynamic context load updates during output generation in AI-based protein and drug design.

Innovation Solution

The Context Load Update Engine (CLUE) model, which is a reasoning model equipped with retrieval augmented generation and an end-to-end differentiably learnable indication mechanism, updates context load during output generation based on the theretofore generated output, using a pre-trained language model with supervised fine tuning and reinforcement learning to confer reasoning and retrieval capabilities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If existing machine learning algorithms are used for drug design, then the basic functionality is provided, but the algorithms cannot effectively leverage massive protein-related information, resulting in lengthy and costly development pipelines

Engineering Contradiction:
Improveprotein-related information utilizationVSAvoiddrug development time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The patent introduces a retrieval-augmented generation system that acts as an intermediary between the language model and protein-related information databases. The system retrieves relevant protein information dynamically during the design process and integrates it into the context window, enabling the model to leverage massive external information without requiring the information to be pre-loaded or hard-coded into the model architecture.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent implements dynamic context window adjustment by allowing the retrieval-augmented system to adaptively update the context based on the current design stage and information needs. The context window is not fixed but dynamically expanded or contracted based on retrieved protein information, enabling flexible information utilization throughout the drug design pipeline.

Inventive Principle:
Principle #15Dynamics

2Loss of information

If context window size is increased to leverage more information, then information availability improves, but computational complexity and processing time increase

Engineering Contradiction:
Improvecontext information availabilityVSAvoidcomputational complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent segments the context window into dynamic components that can be independently managed. Instead of using a single large static context window, the system divides the context into base context and retrieved information segments, allowing selective loading and processing of only the most relevant information segments based on current task requirements.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent dynamically changes the context window parameters (size, content, composition) based on the retrieval-augmented generation process. The system adjusts context parameters adaptively by retrieving and injecting relevant protein information only when needed, rather than maintaining a consistently large context window, thereby reducing average computational complexity while preserving information availability when required.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If dynamic context updates are implemented during output generation, then reasoning accuracy improves, but the system complexity increases

Engineering Contradiction:
Improvereasoning accuracyVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements feedback mechanisms where the generation process itself informs context retrieval decisions. As the language model generates output tokens, the system continuously monitors the generated content and uses it to trigger additional context retrieval when relevant protein information is detected to be needed, creating a closed-loop system that improves reasoning accuracy through iterative refinement.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The retrieval-augmented generation system performs self-service by automatically determining when and what context to retrieve based on the ongoing generation process. The system monitors its own output and autonomously triggers context updates without external intervention, managing its own information needs through self-awareness of the generation state and protein information requirements.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS12531136B2Clue: dynamic context retrieval in reasoning models for AI-based protein and drug design
Publication Date: 2026.01.20 DEEP EIGENMATICS INC
  • US12531136B2 patent drawing
  • US12531136B2 patent drawing
  • US12531136B2 patent drawing

AI summary

Systems, methods, and apparatus for obtaining proteins and small molecules representations for manufacture, using a herein disclosed dynamic Context Load Update Engine (CLUE) during output generation by reasoning models. Pre-trained neural networks equipped with retrieval augmentation and trained on chain-of-thought data for reasoning capacity are used. The pre-trained models are further equipped with an indicator mechanism. During the course of output generation, the indicator mechanism indicates when a need for an update to the context arises; wherein the context is a combination of the input query and the theretofore generated output. Output generation continues between each context update till completion. In one embodiment of the invention, transfer learning is used to train the pre-trained neural network in conjunction with its associated indicator and retrieval mechanisms. The trained system is used to generate representations of proteins or small molecule drugs in response to specifying queries. The generated representations are then manufactured.